# CULLINAN THERAPEUTICS INC (CGEM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CGEM/

- Reporting holders: 4
- Reported value: $68.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $40.9K | 2,666 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $14.5K | 942 | 0.0% | 7 |
| [Bangor Savings Bank](https://holderbook.com/funds/1352675-bangor-savings-bank/) | $12.9K | 842 | 0.0% | 3 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $414 | 27 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $68.7K |
| Q2 2026 | 184 | $1.6B |
| Q1 2026 | 172 | $936.8M |
| Q4 2025 | 154 | $660.1M |
| Q3 2025 | 144 | $365.4M |
| Q2 2025 | 144 | $480.7M |
| Q1 2025 | 148 | $491.7M |
| Q4 2024 | 146 | $801.6M |
| Q3 2024 | 137 | $1.1B |
| Q2 2024 | 135 | $1.1B |
| Q1 2024 | 113 | $712.6M |
| Q4 2023 | 113 | $386.1M |